NASDAQ:INO   Inovio Pharmaceuticals, Inc.
INO is revealing head and neck cancer data on November 8-12
It is currently sitting on its 50 day EMA and a past resistance/support level.
Entry: 6.24
Stop Loss: 5.80
Profit Target: 7.00, maybe more
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.